ACCURAY INC (ARAY) 8-K Current Report: March 19, 2026
Filed: March 19, 2026
Health Care
Surgical & Medical Instruments & ApparatusACCURAY INC (ARAY) 8-K current report filed with SEC EDGAR on March 19, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 5.02: Departure/Election of Directors or Officers
ACCURAY INC 8-K Mar 19, 2026 Event Analysis
Item 5.02 · Departure/Election of Directors or Officers
- • Senior VP, Chief Commercial Officer Sandeep Chalke to depart March 31, 2026
- • Separation agreement includes $459,000 lump sum payment equal to 12 months base salary
- • Equity grants vesting accelerated for May 31, 2026 tranche; later equity forfeited
- • Pro-rated 2026 bonus payable timing aligned with other executives
- • Separation agreement includes general release, superseding prior severance/noncompetition terms
Get deeper insights on ACCURAY INC
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.